Skip to main content
IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
1.740
-0.050 (-2.79%)
At close: Dec 5, 2025, 4:00 PM EST
1.670
-0.070 (-4.02%)
After-hours: Dec 5, 2025, 7:41 PM EST

IM Cannabis Revenue

IM Cannabis had revenue of 13.85M CAD in the quarter ending September 30, 2025, a decrease of -0.23%. This brings the company's revenue in the last twelve months to 52.38M, up 1.92% year-over-year. In the year 2024, IM Cannabis had annual revenue of 54.03M with 10.71% growth.

Revenue (ttm)
52.38M CAD
Revenue Growth
+1.92%
P/S Ratio
0.16
Revenue / Employee
551,389 CAD
Employees
95
Market Cap
9.13M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202454.03M5.23M10.71%
Dec 31, 202348.80M-5.53M-10.18%
Dec 31, 202254.34M20.28M59.56%
Dec 31, 202134.05M18.16M114.30%
Dec 31, 202015.89M6.82M75.12%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

IMCC News

More News